Evidence-based practices in intellectual disability and behaviour disorders

Current Opinion in Psychiatry
Ian M Grey, Richard P Hastings

Abstract

To critically review the most recently published studies on the treatment of challenging behaviours/behaviour disorders for individuals with intellectual disability. Literature published in the review period was from three traditions: applied behaviour analysis, psychopharmacology, and service evaluation. Applied behaviour analysis treatments have a large evidence base, and recent research has focused on refining issues such as dealing with low rate behaviours, improving generalization, the effects of choice-making, and setting event variables that may affect treatment outcomes. Recent interest in risperidone as a treatment for behaviour disorder has dominated the literature on pharmacological interventions. Several empirical studies support the use of risperidone in children, although a recent review is more sceptical of the quality of the evidence to date. A small number of service evaluation studies suggest in particular that applied behaviour analysis technologies can be scaled up to benefit large numbers of patients. Applied behaviour analysis methods for the assessment and treatment of behaviour disorders continue to be the focus of research, and continue to result in positive outcomes. Recent data show the value of using...Continue Reading

References

Jul 16, 2003·Journal of Applied Behavior Analysis·Gregory P HanleyBrandon E McCord
Dec 4, 2003·American Journal of Mental Retardation : AJMR·Steve HolburnPeter M Vietze
Dec 4, 2003·American Journal of Mental Retardation : AJMR·Johannes RojahnErik Mayville
Dec 17, 2003·Journal of Intellectual Disability Research : JIDR·M A FeldmanR Condillac
Jan 9, 2004·Behavior Modification·David B McAdamDeborah A Napolitano
Apr 2, 2004·The American Journal of Psychiatry·Robert L FindlingUNKNOWN Risperidone Disruptive Behavior Study Group
Jun 5, 2004·American Journal of Mental Retardation : AJMR·Janet RobertsonAngela Hallam
Jun 5, 2004·American Journal of Mental Retardation : AJMR·Jennifer R ZarconeStephen R Schroeder
Oct 7, 2004·Pediatrics·Eitan KilchevskyPat Murphy
Oct 27, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Frank J SymonsGeorge Realmuto
Nov 9, 2004·Journal of Applied Behavior Analysis·Jennifer M AsmusDavid P Wacker
Nov 16, 2004·Research in Developmental Disabilities·Jane A McGillivray, Marita P McCabe
Dec 1, 2004·American Journal of Mental Retardation : AJMR·Holly Reed Schindler, Robert H Horner
Dec 14, 2004·Research in Developmental Disabilities·Vanessa A GreenJeff Sigafoos
Dec 14, 2004·Research in Developmental Disabilities·Ethan S LongDawn Resau
Dec 21, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Jan CroonenberghsUNKNOWN Risperidone Disruptive Behavior Study Group
Jan 7, 2005·Journal of Intellectual Disability Research : JIDR·J RobertsonA Hallam
Jan 26, 2005·Research in Developmental Disabilities·Ashvind N SinghPeter Sturmey
Apr 9, 2005·Journal of Intellectual Disability Research : JIDR·B McCleanM Corrigan

❮ Previous
Next ❯

Citations

Oct 21, 2006·Journal of Autism and Developmental Disorders·Elias TsakanikosNick Bouras
Aug 6, 2013·Journal of Mental Health Research in Intellectual Disabilities·Julie F BrownPaige Dibiasio
Apr 21, 2009·American Journal on Intellectual and Developmental Disabilities·Sigan L Hartley, William E Maclean
Sep 5, 2013·Journal of Autism and Developmental Disorders·Tanja SappokAlbert Diefenbacher
Sep 20, 2007·Expert Opinion on Drug Safety·Camilla Haw, Jean Stubbs
Apr 11, 2012·Journal of Applied Research in Intellectual Disabilities : JARID·Sophie WilliamsKathryn McDowell
May 25, 2010·Journal of Intellectual Disability Research : JIDR·Mieke HeyvaertP Onghena
Sep 24, 2015·Journal of Applied Behavior Analysis·Alison D Cox, Javier Virues-Ortega
Jan 18, 2011·Research in Developmental Disabilities·Julie Brosnan, Olive Healy
Sep 26, 2016·Research in Developmental Disabilities·M H KnotterI B Wissink
Nov 21, 2019·Journal of Applied Research in Intellectual Disabilities : JARID·Kim J H M van den BogaardPetri J C M Embregts
Aug 15, 2009·Journal of Intellectual & Developmental Disability·Andy SmidtVicki A Reed
Aug 18, 2016·International Journal of Developmental Disabilities·Ayelet Gur

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.